Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports the construction of conformationally constrained peptidomimetics, enhancing metabolic stability and receptor selectivity. Commonly employed in medicinal chemistry for optimizing drug candidates due to the presence of the difluoromethoxy aromatic group and the Boc-protected pyrrolidine scaffold, which facilitate lipophilicity modulation and ease of further functionalization.